Senti Biosciences Inc. (SNTI)
Senti Biosciences Statistics
Share Statistics
Senti Biosciences has 25.99M shares outstanding. The number of shares has increased by -43.21% in one year.
| Shares Outstanding | 25.99M |
| Shares Change (YoY) | -43.21% |
| Shares Change (QoQ) | 466.31% |
| Owned by Institutions (%) | 5.54% |
| Shares Floating | 7.88M |
| Failed to Deliver (FTD) Shares | 134 |
| FTD / Avg. Volume | 0.42% |
Short Selling Information
The latest short interest is 61.51K, so 0.24% of the outstanding shares have been sold short.
| Short Interest | 61.51K |
| Short % of Shares Out | 0.24% |
| Short % of Float | 0.24% |
| Short Ratio (days to cover) | 2.87 |
Valuation Ratios
The PE ratio is -0.31 and the forward PE ratio is -0.69. Senti Biosciences's PEG ratio is 0.01.
| PE Ratio | -0.31 |
| Forward PE | -0.69 |
| PS Ratio | 0 |
| Forward PS | 29.6 |
| PB Ratio | 0.63 |
| P/FCF Ratio | -0.39 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Senti Biosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.49, with a Debt / Equity ratio of 1.31.
| Current Ratio | 4.49 |
| Quick Ratio | 4.49 |
| Debt / Equity | 1.31 |
| Debt / EBITDA | -0.55 |
| Debt / FCF | -0.81 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.55M |
| Employee Count | 34 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 54.09% in the last 52 weeks. The beta is 2.33, so Senti Biosciences's price volatility has been higher than the market average.
| Beta | 2.33 |
| 52-Week Price Change | 54.09% |
| 50-Day Moving Average | 3.55 |
| 200-Day Moving Average | 3.24 |
| Relative Strength Index (RSI) | 70.78 |
| Average Volume (20 Days) | 32.04K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -61.04M |
| Net Income | -52.79M |
| EBITDA | -61.04M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -11.49 |
Balance Sheet
The company has 48.28M in cash and 33.54M in debt, giving a net cash position of 14.74M.
| Cash & Cash Equivalents | 48.28M |
| Total Debt | 33.54M |
| Net Cash | 14.74M |
| Retained Earnings | -297.13M |
| Total Assets | 97.84M |
| Working Capital | 45.81M |
Cash Flow
In the last 12 months, operating cash flow was -41.4M and capital expenditures -26K, giving a free cash flow of -41.42M.
| Operating Cash Flow | -41.4M |
| Capital Expenditures | -26K |
| Free Cash Flow | -41.42M |
| FCF Per Share | -9.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SNTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for SNTI is $12, which is 177.1% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12 |
| Price Target Difference | 177.1% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jul 18, 2024. It was a backward split with a ratio of 1:10.
| Last Split Date | Jul 18, 2024 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -4.3 |
| Piotroski F-Score | 3 |